Litigation Details for Otsuka Pharmaceutical Co., Ltd. v. Zenara Pharma Private Ltd. (D. Del. 2019)
✉ Email this page to a colleague
Otsuka Pharmaceutical Co., Ltd. v. Zenara Pharma Private Ltd. (D. Del. 2019)
| Docket | ⤷ Try a Trial | Date Filed | 2019-10-11 |
| Court | District Court, D. Delaware | Date Terminated | 2022-10-26 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 10,010,533; 10,307,419; 6,562,375; 7,888,362; 8,008,006; 8,349,840; 8,618,109; 9,265,831; 9,572,796; 9,572,797; 9,839,637 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Otsuka Pharmaceutical Co., Ltd. v. Zenara Pharma Private Ltd.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Biologic Drugs cited in Otsuka Pharmaceutical Co., Ltd. v. Zenara Pharma Private Ltd.
The biologic drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for Otsuka Pharmaceutical Co., Ltd. v. Zenara Pharma Private Ltd. (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2021-07-27 | 126 | Opinion - Memorandum Opinion | one of the five patents-in-suit, U.S. Patent No. 10,307,419 (the '" 419 patent"). The parties…; It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent." Id. at 1321 (internal quotation marks omitted). The patent "specification…;Plaintiffs") allege infringement of five patents against 18 pharmaceutical manufacturers seeking… Plaintiffs' REXULTI® tablets before the patents expire. (D.I. 71 ; D.I. 92 at 1) 1 REXULTI® is | External link to document |
| 2020-05-19 | 15 | Redacted Document | asserted U.S. Patent Nos. 9,265,831; 9,572,796; 9,572,797; and 10,010,533. Case…agree that Claim 1 of U.S. Patent No. 9,572,796 (“the ’796 patent”), shown below in relevant…from the patent disclosures is that a skilled artisan would understand the patents to disclose…on the Pleadings of Noninfringement of the '419 Patent by Biophore India Pharmaceuticals Private Ltd.,… Slayback Pharma LLC for infringing four patents covering Eagle’s brand name bendamustine | External link to document |
| 2019-10-11 | 4 | Patent/Trademark Report to Commissioner of Patents | ,349,840; 8,618,109; 9,839,637; 10,307,419. (nmg) (Entered: 10/15/2019) 11 October 2019 PACER … Otsuka Pharmaceutical Co., Ltd. 5 10,307,419 06/04/2019 … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,888,362; 8,349,840… or G Patents. ✔ ( G the patent action involves… PRIVATE LTD. PATENT OR DATE OF PATENT | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
